Traws Pharma, Inc. (TRAW) Operating margin 2015–2024
Traws Pharma, Inc. (TRAW) operating margin by fiscal year — reported operating income divided by reported revenue.
-640.7%FY2024 · since FY2015: -427.4% → -640.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -640.7% | +62356.7 pp |
| FY2023 | -62997.3% | -54015.9 pp |
| FY2022 | -8981.4% | -296.9 pp |
| FY2021 | -8684.5% | -1385.4 pp |
| FY2020 | -7299.1% | +3520.4 pp |
| FY2019 | -10819.5% | -9825.5 pp |
| FY2018 | -994.0% | +901.9 pp |
| FY2017 | -1895.9% | +1374.3 pp |
| FY2016 | -3270.3% | -2842.9 pp |
| FY2015 | -427.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice